Hochberg: Rheumatology 5th edition 2 Volume Set (Expert Consult Series)






The fifth edition of Rheumatology is:
  • The most comprehensive, authoritative rheumatology text, designed to meet the complete needs of all practicing and academic rheumatologists as well as arthritis-related health professionals and scientists interested in disorders of the musculoskeletal system.
  • Firmly grounded on modern biomedical science, integrating the relevant basic biology with current clinical practice.
  • Easily accessible, user-friendly, and a beautifully illustrated color publication.
  • Consistent in style and format, with each chapter written to a strict template and rigorously edited.
  • A genuinely international book, with editors, authors, and material drawn from all over the world.
  • Fully up-to-date, with carefully selected references to original work and key reviews up to and including articles published in the peer-reviewed literature through 2009.

The Fifth Edition of Rheumatology is a Comprehensive and Exciting Book

The international team of editors representing a broad spectrum of academic and clinical rheumatology and biomedical, clinical, and epidemiological research has again brought together a group of internationally renowned authors to deliver essential information on the scientific basis of rheumatic disease and the definition, epidemiology, pathophysiology, clinical features, and management of all musculoskeletal and rheumatic disorders.

Rheumatology, fifth edition, builds on the success of the fourth edition. As stated by Professor Jan Dequeker in his review: “The fourth edition of Rheumatology is the most comprehensive authoritative rheumatology text designed to meet the complete needs of all practicing and academic rheumatologists as well as arthritis-related health care professionals and scientists interested in disorders of the musculoskeletal system. The edition is firmly grounded on modern medical science, integrating the relevant basic biology with current clinical practice, easily accessible, user-friendly and a beautifully illustrated color publication.”

For the fifth edition, every chapter has either been carefully revised or, in many cases, completely rewritten. The Editors have pursued a rigorous editorial policy in order to ensure that the content and format of the book remain both consistent and of the highest possible standard so that each chapter contains the latest information in the field. There are 23 new chapters that provide new information on basic biomedical science, including the emerging field of osteoimmunology, clinical therapeutics, including cell- and gene-based therapies, disease and outcome assessment, including new imaging modalities, and patient management and rehabilitation, including new treatments for rheumatoid arthritis. In an effort to streamline the text even further, chapter contributors have provided their “top 50” references in the book only; the remaining references are found online, all with a link to PubMed. We have also continued to improve the index, in order to make it easier for the reader to find the material that she or he wants.

The fifth edition can be found entirely online at www.expertconsult.com. Besides fully searchable text, you will also find a complete library of easily downloadable electronic images, links to PubMed and key society web sites, and continuous content updates from two dedicated web editors.


Book Features 
  • Designed to meet the needs of the practicing clinician, it provides extensive, authoritative coverage of rheumatic disease from basic scientific principles to practical points of clinical management in a lucid, logical, user-friendly manner. 
  • Access the complete contents online - fully searchable with monthly content updates, links to PubMed and CrossRef, outcome measurement tools, classification criteria, self assessment tools, and more.
  • Find the critical answers you need quickly and easily thanks to a consistent, highly user-friendly format covering all major disorders of the musculoskeletal system in complete, self-contained chapters.


Website Features
  • Consult the book from any computer at home, in your office, or at any practice location.
  • Instantly locate the answers to your clinical questions via a simple search query.
  • Quickly find out more about any bibliographical citation by linking to its MEDLINE abstract.
  • Images: Browse a Library of all book images. Easily select, organize, and download your images into a presentation.

Get trusted perspectives and insights from chapters co-authored by internationally renowned leaders in the field, 25% of whom are new to this edition.
  • Track disease progression and treat patients more effectively with the most current information, including 22 new chapters on genetic findings, imaging outcomes, and cell and biologic therapies as well as rheumatoid arthritis and SLE.
  • Incorporate the latest findings about pathogenesis of disease; imaging outcomes for specific diseases like RA, osteoarthritis, and spondyloarthropathies; cell and biologic therapies; and other timely topics.
Search the full text online at expertconsult.com with monthly content updates, a downloadable image collection, outcome measurement tools, classification criteria, self assessment tools, and more. 

Fully revised, the new edition of the celebrated Hochberg is a must-have for every rheumatologist. 


Contents 
Section 1 - The scientific basis of rheumatic disease
  • Chapter 1 - Epidemiologic concepts and the classification of musculoskeletal conditions
  • Chapter 2 - Principles of clinical outcome assessment
  • Chapter 3 - Principles of health economics and application to rheumatic disorders
  • Chapter 4 - Biomechanics of the spine
  • Chapter 5 - Biomechanics of peripheral joints
  • Chapter 6 - Connective tissue responses to mechanical stresses
  • Chapter 7 - The synovium
  • Chapter 8 - The articular cartilage
  • Chapter 9 - Bone structure and function
  • Chapter 10 - Tendons and ligaments
  • Chapter 11 - Cytokines
  • Chapter 12 - Principles and techniques in molecular biology
  • Chapter 13 - Signal transduction
  • Chapter 14 - Genetic factors in rheumatic disease
  • Chapter 15 - The principles of adaptive immunity
  • Chapter 16 - Principles of innate immunity
  • Chapter 17 - Tissue destruction and repair
  • Chapter 18 - Principles of tissue engineering and cell- and gene-based therapy
  • Chapter 19 - Osteoimmunology
  • Chapter 20 - The complement system in systemic lupus erythematosus
  • Chapter 21 - Inflammation
  • Chapter 22 - Scientific basis of pain
  • Chapter 23 - Pharmacogenomics in rheumatology
  • Chapter 24 - Effects of the neuroendocrine system on development and function of the immune system
  • Chapter 25 - Interpreting the medical literature for the rheumatologist: Study design and levels of evidence
  • Chapter 26 - Ethics in clinical trials

Section 2 - Clinical basis of rheumatic disease
  • Chapter 27 - History and physical examination
  • Chapter 28 - Pattern recognition in arthritis
  • Chapter 29 - Role of laboratory tests in rheumatic disorders
  • Chapter 30 - Synovial fluid analysis
  • Chapter 31 - Minimally invasive procedures
  • Chapter 32 - Skin in rheumatic disease
  • Chapter 33 - The eye in rheumatic disease
  • Chapter 34 - The heart in rheumatic disease
  • Chapter 35 - The lung in rheumatic disease
  • Chapter 36 - Gastrointestinal tract and rheumatic disease
  • Chapter 37 - The kidney and rheumatic disease

Section 3 - Evaluation: imaging techniques
  • Chapter 38 - Conventional radiography and computed tomography
  • Chapter 39 - Magnetic resonance imaging
  • Chapter 40 - Musculoskeletal ultrasound
  • Chapter 41 - Bone scintigraphy and positron emission tomography
  • Chapter 42 - DXA and measurement of bone
  • Chapter 43 - Use of imaging as an outcome measure in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis in clinical trials

Section 4 - Principles of management
  • Chapter 44 - Arthritis patient education and team approaches to management
  • Chapter 45 - Nutrition in rheumatic disease
  • Chapter 46 - Principles of rehabilitation: Physical and occupational therapy
  • Chapter 47 - Complementary and alternative medicine
  • Chapter 48 - Non-pharmacologic pain management
  • Chapter 49 - Principles of opioid treatment of chronic musculoskeletal pain
  • Chapter 50 - Non-steroidal anti-inflammatory drugs
  • Chapter 51 - Systemic glucocorticoids in rheumatology
  • Chapter 52 - Parenteral gold, antimalarials, and sulfasalazine
  • Chapter 53 - Methotrexate
  • Chapter 54 - Leflunomide
  • Chapter 55 - Immunosuppressives (chlorambucil, cyclosporine, cyclophosphamide [Cytoxan], azathioprine [Imuran], mofetil, tacrolimus)
  • Chapter 56 - Dapsone, penicillamine, thalidomide, bucillamine, and the tetracyclines
  • Chapter 57 - Immunotherapies: T cell and complement
  • Chapter 58 - T-cell co-stimulation
  • Chapter 59 - Rituximab
  • Chapter 60 - Cytokine neutralizers: IL-1 inhibitors
  • Chapter 61 - Tumor necrosis factor blocking therapies
  • Chapter 62 - Tyrosine kinase inhibition
  • Chapter 63 - Emerging therapeutic targets: IL-15, IL-17, IL-18, and IL-23
  • Chapter 64 - Infections and biologic therapy in rheumatoid arthritis
  • Chapter 65 - Drugs and pregnancy
  • Chapter 66 - Aspiration and injection of joints and periarticular tissues and intralesional therapy
  • Chapter 67 - Perioperative care of the rheumatic disease patient

Section 5 - Regional and widespread pain
  • Chapter 68 - Neck pain
  • Chapter 69 - Lumbar spine disorders
  • Chapter 70 - The shoulder
  • Chapter 71 - The elbow
  • Chapter 72 - The wrist and hand
  • Chapter 73 - The hip
  • Chapter 74 - The knee
  • Chapter 75 - The ankle and foot
  • Chapter 76 - The temporomandibular joint
  • Chapter 77 - Fibromyalgia and related syndromes
  • Chapter 78 - Entrapment neuropathies and compartment syndromes
  • Chapter 79 - Complex regional pain syndrome (reflex sympathetic dystrophy)
  • Chapter 80 - Sports medicine: Clinical spectrum of injury

Section 6 - Rheumatoid arthritis and other synovial disorders
  • Chapter 81 - Classification and epidemiology of rheumatoid arthritis
  • Chapter 82 - Clinical features of rheumatoid arthritis
  • Chapter 83 - Extra-articular features of rheumatoid arthritis and systemic involvement
  • Chapter 84 - Adult-onset Still's disease
  • Chapter 85 - Imaging of rheumatoid arthritis
  • Chapter 86 - The contribution of genetic factors to rheumatoid arthritis
  • Chapter 87 - Animal models of arthritis
  • Chapter 88 - Autoantibodies in rheumatoid arthritis
  • Chapter 89 - Cellular immunity in rheumatoid arthritis
  • Chapter 90 - Angiogenesis in rheumatoid arthritis
  • Chapter 91 - The rheumatoid joint: Synovitis and tissue destruction
  • Chapter 92 - Evaluation and management of early inflammatory polyarthritis
  • Chapter 93 - Evaluation and outcomes of patients with rheumatoid arthritis
  • Chapter 94 - Management of rheumatoid arthritis: Synovitis
  • Chapter 95 - Multidisciplinary approach to rheumatoid arthritis 

Section 7 - Pediatric rheumatology
  • Chapter 96 - Evaluation of musculoskeletal complaints in children
  • Chapter 97 - Classification and epidemiology of juvenile idiopathic arthritis
  • Chapter 98 - Presentations, clinical features, and special problems in children 
  • Chapter 99 - Etiology and pathogenesis of juvenile idiopathic arthritis 
  • Chapter 100 - Management of juvenile idiopathic arthritis
  • Chapter 101 - The juvenile-onset spondyloarthropathies
  • Chapter 102 - Connective tissue diseases in children
  • Chapter 103 - Rehabilitation and psychosocial issues in juvenile idiopathic arthritis

Section 8 - Infection-related rheumatic diseases
  • Chapter 104 - Septic arthritis, osteomyelitis, and gonococcal and syphilitic arthritis
  • Chapter 105 - Mycobacterial, brucellar, fungal, and parasitic arthritis
  • Chapter 106 - Lyme disease
  • Chapter 107 - Rheumatologic aspects of viral infections
  • Chapter 108 - Acute rheumatic fever
  • Chapter 108 - Acute rheumatic fever
  • Chapter 109 - Reactive arthritis: Etiology and pathogenesis
  • Chapter 110 - Reactive arthritis: Clinical features and treatment

Section 9 - Spondyloarthropathies
  • Chapter 111 - Classification and epidemiology of spondyloarthritis
  • Chapter 112 - Clinical features of ankylosing spondylitis
  • Chapter 113 - Etiology, pathogenesis, and pathophysiology of ankylosing spondylitis
  • Chapter 114 - Genetics of ankylosing spondylitis
  • Chapter 115 - Seronegative spondyloarthropathies: Imaging
  • Chapter 116 - Management of ankylosing spondylitis
  • Chapter 117 - Classification and epidemiology of psoriatic arthritis
  • Chapter 118 - Clinical features of psoriatic arthritis
  • Chapter 119 - Etiology and pathogenesis of psoriatic arthritis
  • Chapter 120 - Management of psoriatic arthritis
  • Chapter 121 - Enthesopathies

Section 10 - Connective tissue disorders
  • Chapter 122 - Epidemiology and classification of systemic lupus erythematosus
  • Chapter 123 - Clinical features of systemic lupus erythematosus
  • Chapter 124 - Genetics of lupus
  • Chapter 125 - Immunopathology of systemic lupus erythematosus
  • Chapter 126 - Animal models of lupus
  • Chapter 127 - Autoantibodies in systemic lupus erythematosus
  • Chapter 128 - Pathogenesis of lupus
  • Chapter 129 - Drug-induced lupus
  • Chapter 130 - Assessing disease activity and outcome in systemic lupus erythematosus
  • Chapter 131 - Treatment of non-renal lupus
  • Chapter 132 - Systemic lupus erythematosus: Treatment—renal involvement
  • Chapter 133 - Systemic lupus erythematosus in the pregnant patient and neonatal lupus
  • Chapter 134 - Sjogren syndrome
  • Chapter 135 - Antiphospholipid syndrome: Overview of pathogenesis, diagnosis, and management
  • Chapter 136 - Epidemiology and classification of scleroderma
  • Chapter 137 - Assessing disease activity and outcome in scleroderma
  • Chapter 138 - Clinical features of systemic sclerosis
  • Chapter 139 - Pathogenesis of systemic sclerosis
  • Chapter 140 - Management of systemic sclerosis
  • Chapter 141 - Pulmonary management of systemic sclerosis
  • Chapter 142 - Raynaud's phenomenon
  • Chapter 143 - Localized scleroderma and scleroderma-like syndromes
  • Chapter 144 - Clinical features, classification, and epidemiology of inflammatory muscle disease
  • Chapter 145 - Inflammatory muscle disease—etiology and pathogenesis (myositis)
  • Chapter 146 - Management of inflammatory muscle disease
  • Chapter 147 - Metabolic, drug-induced, and other non-inflammatory myopathies
  • Chapter 148 - Overlap syndromes

Section 11 - The vasculitides
  • Chapter 149 - Classification and epidemiology of vasculitis
  • Chapter 150 - Biology and immunopathogenesis of vasculitis
  • Chapter 151 - Polyarteritis nodosa and microscopic polyangiitis
  • Chapter 152 - Polymyalgia rheumatica and giant cell arteritis
  • Chapter 153 - Wegener's granulomatosis
  • Chapter 154 - Churg-Strauss syndrome
  • Chapter 155 - Takayasu's arteritis
  • Chapter 156 - Behcet's syndrome
  • Chapter 157 - Kawasaki disease
  • Chapter 158 - Henoch-Schonlein purpura
  • Chapter 159 - Cutaneous vasculitis and panniculitis
  • Chapter 160 - Cryoglobulinemia
  • Chapter 161 - Primary angiitis of the central nervous system
  • Chapter 162 - Cogan's syndrome

Section 12 - Other systemic illnesses
  • Chapter 163 - Hereditary recurrent fevers
  • Chapter 164 - Sarcoidosis
  • Chapter 165 - Relapsing polychondritis
  • Chapter 166 - Miscellaneous arthropathies including synovial tumors and foreign body synovitis and nephrogenic systemic fibrosis
  • Chapter 167 - Amyloidosis
  • Chapter 168 - Digital clubbing and hypertrophic osteoarthropathy

Section 13 - Osteoarthritis and related disorders
  • Chapter 169 - Osteoarthritis: Epidemiology and classification
  • Chapter 170 - Local and systemic risk factors for incidence and progression of osteoarthritis
  • Chapter 171 - Clinical features of osteoarthritis
  • Chapter 172 - Animal models of osteoarthritis
  • Chapter 173 - Pathogenesis and pathology of osteoarthritis
  • Chapter 174 - Genetics of osteoarthritis
  • Chapter 175 - Imaging of osteoarthritis
  • Chapter 176 - Assessment of the patient with osteoarthritis and measurement of outcomes
  • Chapter 177 - Assessment of imaging outcomes in osteoarthritis
  • Chapter 178 - Management of osteoarthritis
  • Chapter 179 - Diffuse idiopathic skeletal hyperostosis
  • Chapter 180 - Neuropathic arthropathy
  • Chapter 181 - Osteonecrosis 
  • Chapter 182 - Rare osteoarthritis: Ochronosis, Kashin-Beck disease, and Mseleni joint disease

Section 14 - Crystal-related arthropathies
  • Chapter 183 - Etiology and pathogenesis of gout
  • Chapter 184 - Clinical gout
  • Chapter 185 - The management of gout and hyperuricemia
  • Chapter 186 - Calcium pyrophosphate crystal-associated arthropathy
  • Chapter 187 - Basic calcium phosphate crystal deposition disease
  • Chapter 188 - Other crystal-related arthropathies

Section 15 - Endocrine and hemoglobin-related arthritis and storage disease
  • Chapter 189 - Rheumatoid manifestations of endocrine and lipid disease
  • Chapter 190 - Hemophilia and vonWillebrand disease
  • Chapter 191 - Joint and bone lesions in hemoglobinopathies
  • Chapter 192 - Hemochromatosis

Section 16 - Metabolic bone disease
  • Chapter 193 - Epidemiology and classification of metabolic bone disease
  • Chapter 194 - Osteoporosis: Clinical features of osteoporosis
  • Chapter 195 - Pathogenesis of osteoporosis
  • Chapter 196 - Biochemical markers in bone disease
  • Chapter 197 - Management of osteoporosis
  • Chapter 198 - Glucocorticoid-induced osteoporosis
  • Chapter 199 - Osteomalacia and rickets
  • Chapter 200 - Primary hyperparathyroidism: Rheumatologic manifestations and bone disease
  • Chapter 201 - Renal osteodystrophy
  • Chapter 202 - Paget's disease of bone

Section 17 - Heritable disease and tumors of bone and connective tissue
  • Chapter 203 - Gaucher's disease
  • Chapter 204 - Mucopolysaccharidoses
  • Chapter 205 - Heritable connective tissue disorders
  • Chapter 206 - Hypermobility syndrome
  • Chapter 207 - Skeletal dysplasias
  • Chapter 208 - Bone tumors


About the Authors
  • Marc C. Hochberg, MD, MPH, Professor of Medicine, Head, Division of Rheumatology and Clinical Immunology, University of Maryland School of Medicine, Baltimore, MD, USA; 
  • Alan J. Silman, MD, ARC Professor of Rheumatic Disease Epidemiology, Director, ARC Epidemiology Research Unit, University of Manchester, UK; 
  • Josef S. Smolen, MD, Department of Internal Medicine, University of Vienna and Center for Rheumatic Diseases, Lainz Hospital, Vienna, Austria; 
  • Michael E. Weinblatt, MD, Professor of Medicine, Harvard Medical School, Co-Director of Clinical Rheumatology, Brigham and Women's Hospital, Boston, MA and 
  • Michael H. Weisman, MD, Director, Division of Rheumatology, Cedars-Sinai Medical Center; Professor of Medicine, University of California at Los Angeles Medical Center, Los Angeles, CA, USA


Book Details

  • Hardcover: 2228 pages
  • Publisher: Mosby; 5 edition (October 19, 2010)
  • Language: English
  • ISBN-10: 0323065511
  • ISBN-13: 978-0323065511
  • Product Dimensions: 12.5 x 10.5 x 3.9 inches
List Price: $435.00 
 
 

Medical Lecture Note Copyright © 2011